title: Epigenetic cancer therapies emerge out of the lab into the limelight.
authors.affiliation: wendywolfson@nasw.org
authors.forename: Wendy
authors.initials: W
authors.lastname: Wolfson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D047630:Depsipeptides / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D057890:Epigenomics; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D011725:Pyridines / Q000627:therapeutic use; D000077337:Vorinostat
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D047630:Depsipeptides; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D011725:Pyridines; C118739:entinostat; D000077337:Vorinostat; C087123:romidepsin; D001374:Azacitidine